Last updated: 3 months ago
Benitec Biopharma Inc. (BNTC) Q4 2024 Financial Report: Insights & Future Strategies
Explore Benitec Biopharma's Q4 2024 financial performance, key metrics, and strategic outlook amid ongoing losses and R&D investments.
Posts With Tag RNA Interference
Showing 1 - 2 of 2 Posts
Last updated: 3 months ago
Arrowhead Pharmaceuticals Q4 2024 Financial Report: Losses & Promising Collaborations
Explore Arrowhead Pharmaceuticals' Q4 2024 report highlighting a $173.1M net loss, $578.3M in securities, and strategic partnerships worth up to $14.1B. Investment recommendation: Hold.